The role of glutamate signaling in melanoma has been the subject of investigation for several studies, which reported that melanoma cells express different types of glutamate receptors, over 60% of human melanomas expressing metabotropic glutamate receptors, including mGluR1 and 5 [99,100,101]. This evidence concerns the gene GRM1 and melanoma.